{"version":"1.0","width":620,"height":178,"type":"rich","provider_name":"LISTEN","provider_url":"https:\/\/listen.style","url":"https:\/\/listen.style\/p\/ovisbxty\/nhizoctx\/player","title":"E129: Sam Altman plays chess with regulators, AI's \"nuclear\" potential, big pharma bundling & more","author_name":"All-In Podcast, LLC","author_url":"https:\/\/listen.style\/p\/ovisbxty","html":"<iframe src=\"https:\/\/listen.style\/p\/ovisbxty\/nhizoctx\/player\" title=\"E129: Sam Altman plays chess with regulators, AI's \"nuclear\" potential, big pharma bundling & more\" scrolling=\"no\" frameborder=\"0\" style=\"width: 100%; height: 178px;\"><a href=\"https:\/\/listen.style\/p\/ovisbxty\/nhizoctx\/player\">E129: Sam Altman plays chess with regulators, AI's \"nuclear\" potential, big pharma bundling & more<\/a><\/iframe>"}